search
Back to results

The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
mesenchymal stem cell
Placebo
Sponsored by
Royan Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring knee joint osteoarthritis mesenchymal stem cell

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Osteoarthritis diagnosed by MRI

Exclusion Criteria:

  • Pregnancy or lactating
  • Positive tests for HIV, HCV, HBV
  • Active neurologic disorder
  • End organ damage
  • Uncontrolled endocrine disorder

Sites / Locations

  • Royan Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

mesenchymal stem cell

placebo

Arm Description

Patients with knee joint osteoarthritis who underwent intra articular mesenchymal stem cell injection.

The patients who are in control group and underwent placebo injection.

Outcomes

Primary Outcome Measures

physical function improvement
Evaluation the physical function improvement Measured by WOMAC osteoarthritis index after cell injection.
change in pain density
Evaluation the changing of pain density measured by Visual Analogue Scale after cell injection.

Secondary Outcome Measures

joint swelling
Evaluation the joint swelling by physical examination after intra articular cell injection.
joint erythema
Evaluation the joint erythem by physical examination after cell injection
deterioration of joint function
Evaluation the deterioration of joint function by physical examination after intra articular cell injection.
Allergic reactions
Evaluation the allergic reactions like skin rash,skin erythema,dyspenea by physical examination after cell injection

Full Information

First Posted
January 3, 2012
Last Updated
May 15, 2016
Sponsor
Royan Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT01504464
Brief Title
The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis
Official Title
Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells in Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2015
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
October 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royan Institute

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Osteoarthritis of the knee is one of the most common causes of disability among elderly. As the disease progresses the cartilage become frustrated, surrounding bone react to become thicker and inflammation occurs in subchondral bone seen in T2-weighted MRI as increase in signal density. Patients are treated initially by pain management. In patients who don't response to first line treatment invasive treatment like total knee replacement is done. The investigators designed this clinical study with the aim of evaluating therapeutic effects of intra-articular injection of bone marrow mesenchymal stem cells (BM-MSCs) in patients with severe knee osteoarthritis.
Detailed Description
This is single center, randomized, triple blind phase II clinical study. Patients will be divided into two groups of case and control. All subjects will undergo bone marrow aspiration. Mesenchymal stem cells will be isolated from bone marrow, cultured and transplanted back to the knee joint. Patients of case group will receive cell injection 1 and 4 months after bone marrow aspiration. Placebo will be administered in this group 6 months after the first injection. Patients of control group will receive placebo 1 and 4 months after bone marrow aspiration. They all receive cell injection 6 months after first placebo injection. Follow up visit will occur at 2 and 6 weeks, and 3 and 6 months after the first injection. Radiological exams will be performed before and 6 months after the first injection by MRI. Clinical quantitative assessment will measure joint function by the WOMAC index and pain by the visual analogue scale.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
knee joint osteoarthritis mesenchymal stem cell

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
mesenchymal stem cell
Arm Type
Experimental
Arm Description
Patients with knee joint osteoarthritis who underwent intra articular mesenchymal stem cell injection.
Arm Title
placebo
Arm Type
Experimental
Arm Description
The patients who are in control group and underwent placebo injection.
Intervention Type
Biological
Intervention Name(s)
mesenchymal stem cell
Other Intervention Name(s)
stem cell transplantation
Intervention Description
intra articular injection of mesenchymal stem cell
Intervention Type
Biological
Intervention Name(s)
Placebo
Intervention Description
Patients with knee joint osteoarthritis who underwent intra articular placebo injection
Primary Outcome Measure Information:
Title
physical function improvement
Description
Evaluation the physical function improvement Measured by WOMAC osteoarthritis index after cell injection.
Time Frame
2weeks
Title
change in pain density
Description
Evaluation the changing of pain density measured by Visual Analogue Scale after cell injection.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
joint swelling
Description
Evaluation the joint swelling by physical examination after intra articular cell injection.
Time Frame
3months
Title
joint erythema
Description
Evaluation the joint erythem by physical examination after cell injection
Time Frame
3months
Title
deterioration of joint function
Description
Evaluation the deterioration of joint function by physical examination after intra articular cell injection.
Time Frame
3months
Title
Allergic reactions
Description
Evaluation the allergic reactions like skin rash,skin erythema,dyspenea by physical examination after cell injection
Time Frame
3months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Osteoarthritis diagnosed by MRI Exclusion Criteria: Pregnancy or lactating Positive tests for HIV, HCV, HBV Active neurologic disorder End organ damage Uncontrolled endocrine disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hamid Gourabi, PhD
Organizational Affiliation
Head of Royan Institute
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Nasser Aghdami, MD,PhD
Organizational Affiliation
Head of Royan Cell therapy Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Mohsen Emadeddin, MD
Organizational Affiliation
scientist
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royan Institute
City
Tehran
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Learn more about this trial

The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis

We'll reach out to this number within 24 hrs